1100 13th Street, NW, Suite 750Washington, DC 20005202.887.6400Toll-free: 800.544.0155
All Contents © 2018The Kiplinger Washington Editors
Biotech stocks typically are considered one of Wall Street’s more aggressive sources of growth. These companies spend years and gobs of money to create breakthrough biological treatments and diagnostic...
Seth Klarman was prescient in recognizing that the genomics revolution would supercharge the biotech industry.
The key to picking actively managed funds for the year ahead: Think defense
More Investing News »